Glucagon-like peptide 2 (GLP-2) stimulates postprandial chylomicron production and postabsorptive release of intestinal triglyceride storage pools via induction of nitric oxide signaling in male hamsters and mice

Endocrinology (United States)

Volumn 156, Issue 10, 2015, Pages 3538-3547

  Hsieh, Joanne ^a,b   Trajcevski, Karin E ^a,b   Farr, Sarah L ^a,b   Baker, Christopher L ^a   Lake, Elizabeth J ^a   Taher, Jennifer ^a,b   Iqbal, Jahangir ^c   Hussain, Mahmood M ^c   Adeli, Khosrow ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B48; CHYLOMICRON; GLUCAGON LIKE PEPTIDE 2; GLUTATHIONE; HYDROGEN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OLEIC ACID; OLIVE OIL; TRIACYLGLYCEROL; TRIOLEIN; TRITIUM; INSULIN; LIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; CONTROLLED STUDY; DOWN REGULATION; DYSLIPIDEMIA; ENZYME ACTIVATION; EX VIVO STUDY; EXPERIMENTAL HAMSTER; FATTY ACID TRANSPORT; GENE INACTIVATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; LIPID ABSORPTION; LIPID ANALYSIS; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SYRIAN HAMSTER; TRACE METAL BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; CYTOLOGY; HAMSTER; INSULIN RESISTANCE; KNOCKOUT MOUSE; MESOCRICETUS; METABOLISM;

ANIMALS; CHYLOMICRONS; CRICETINAE; DYSLIPIDEMIAS; ENTEROCYTES; GLUCAGON-LIKE PEPTIDE 2; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MALE; MESOCRICETUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; POSTPRANDIAL PERIOD; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84943647133     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/EN.2015-1110     Document Type: Article

References (56)

1. Zilversmit DB. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem. 1995;41(1):153-158.
2. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 1994;106(1):83-97.
3. Duez H, Lamarche B, Uffelman KD, Valero R, Cohn JS, Lewis GF. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol. 2006;26(6):1357-1363.
4. Haidari M, Leung N, Mahbub F, et al. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem. 2002;277(35):31646-31655.
5. Pavlic M, Xiao C, Szeto L, Patterson BW, Lewis GF. Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids. Diabetes. 2010;59(3):580-587.
6. Hsieh J, Longuet C, Baker CL, et al. The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice. Diabetologia. 2010;53(3):552-561.
7. Hsieh J, Longuet C, Maida A, et al. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology. 2009;137(3):997-1005, 1005.e1-e4.
8. Dash S, Xiao C, Morgantini C, Connelly PW, Patterson BW, Lewis GF. Glucagon-like peptide 2 regulates release of chylomicron from the intestine. Gastroenterology. 2014;147(6):1275-1284.e4.
9. Jeppesen PB. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2014;38(1 suppl):45S-52S.
10. Orskov C, Hartmann B, Poulsen SS, Thulesen J, Hare KJ, Holst JJ. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept. 2005;124(1-3): 105-112.
11. Yusta B, Huang L, Munroe D, et al. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology. 2000;119(3):744-755.
12. Guan X, Karpen HE, Stephens J, et al. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology. 2006;130(1): 150-164.
13. Guan X, Stoll B, Lu X, et al. GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1. Gastroenterology. 2003;125(1):136-147.
14. Duez H, Lamarche B, Valéro R, et al. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. Circulation. 2008;117(18): 2369-2376.
15. Korkmaz H, BlochW,Bölck B, Labbé D, Addicks K, Arnhold S. The developmental stage and cell type dependent phosphorylation of eNOS in murine enteric mucosa and myenteric plexus. J Mol Histol. 2007;38(3):227-235.
16. Guo Q, Avramoglu RK, Adeli K. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids. Metabolism. 2005;54(5):689-697.
17. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497-509.
18. Athar H, Iqbal J, Jiang XC, Hussain MM. A simple, rapid, and sensitive fluorescence assay for microsomal triglyceride transfer protein. J Lipid Res. 2004;45(4):764-772.
19. Raabe M, Véniant MM, Sullivan MA, et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest. 1999;103(9):1287-1298.
20. Deniz M, Bozkurt A, Kurtel H. Mediators of glucagon-like peptide 2-induced blood flow: responses in different vascular sites. Regul Pept. 2007;142(1-2):7-15.
21. Iqbal J, Hussain MM. Intestinal lipid absorption. Am J Physiol Endocrinol Metab. 2009;296(6):E1183-E1194.
22. Savidge TC, Newman P, Pothoulakis C, et al. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology. 2007;132(4):1344-1358.
23. Robertson MD, Parkes M, Warren BF, et al. Mobilisation of enterocyte fat stores by oral glucose in humans. Gut. 2003;52(6):834-839.
24. Brubaker PL, Izzo A, Hill M, Drucker DJ. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol. 1997;272(6 Pt 1):E1050-E1058.
25. Meier JJ, Nauck MA, Pott A, et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology. 2006;130(1):44-54.
26. Schild L, Dombrowski F, Lendeckel U, Schulz C, Gardemann A, Keilhoff G. Impairment of endothelial nitric oxide synthase causes abnormal fat and glycogen deposition in liver. Biochim Biophys Acta. 2008;1782(3):180-187.
27. Doulias PT, Greene JL, Greco TM, et al. Structural profiling of endogenous S-nitrosocysteine residues reveals unique features that accommodate diverse mechanisms for protein S-nitrosylation. Proc Natl Acad Sci USA. 2010;107(39):16958-16963.
28. Oliveira CP, Alves VA, Lima VM, et al. Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice. Biochem Pharmacol. 2007; 74(2):290-297.
29. Iqbal J, Li X, Chang BH, et al. An intrinsic gut leptin-melanocortin pathway modulates intestinal microsomal triglyceride transfer protein and lipid absorption. J Lipid Res. 2010;51(7):1929-1942.
30. Lewis GF, Naples M, Uffelman K, Leung N, Szeto L, Adeli K. Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters. Endocrinology. 2004;145(11):5006-5012.
31. Storch J, Zhou YX, Lagakos WS. Metabolism of apical versus basolateral sn-2-monoacylglycerol and fatty acids in rodent small intestine. J Lipid Res. 2008;49(8):1762-1769.
32. Luiking YC, Ten Have GA, Wolfe RR, Deutz NE. Arginine de novo and nitric oxide production in disease states. Am J Physiol Endocrinol Metab. 2012;303(10):E1177-E1189.
33. Guzik TJ, Mussa S, Gastaldi D, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105(14):1656-1662.
34. Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation. 1997;96(1): 25-28.
35. Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003;111(8):1201-1209.
36. Maier W, Cosentino F, Lütolf RB, et al. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol. 2000;35(2):173-178.
37. Xiao C, Hsieh J, Adeli K, Lewis GF. Gut-liver interaction in triglyceride-rich lipoprotein metabolism. Am J Physiol Endocrinol Metab. 2011;301(3):E429-E446.
38. Chavez-Jauregui RN, Mattes RD, Parks EJ. Dynamics of fat absorption and effect of sham feeding on postprandial lipema. Gastroenterology. 2010;139(5):1538-1548.
39. Evans K, Kuusela PJ, Cruz ML, Wilhelmova I, Fielding BA, Frayn KN. Rapid chylomicron appearance following sequential meals: effects of second meal composition. Br J Nutr. 1998;79(5):425-429.
40. Ockner RK, Hughes FB, Isselbacher KJ. Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption. J Clin Invest. 1969;48(12):2367-2373.
41. Ockner RK, Hughes FB, Isselbacher KJ. Very low density lipoproteins in intestinal lymph: origin, composition, and role in lipid transport in the fasting state. J Clin Invest. 1969;48(11):2079-2088.
42. Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012;9(5):286-294.
43. Dixon JB. Mechanisms of chylomicron uptake into lacteals.AnnNY Acad Sci. 2010;1207:E52-E57.
44. Cinci L, Faussone-Pellegrini MS, Rotondo A, Mulè F, Vannucchi MG. GLP-2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility. Neurogastroenterol Motil. 2011;23(9):e383-e392.
45. Sigalet DL, Wallace L, De Heuval E, Sharkey KA. The effects of glucagon-like peptide 2 on enteric neurons in intestinal inflammation. Neurogastroenterol Motil. 2010;22(12):1318-e350.
46. Bulut K, Pennartz C, Felderbauer P, et al. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts. Eur J Pharmacol. 2008;578(2-3):279-285.
47. Rask-Madsen C, King GL. Differential regulation of VEGF signaling by PKC-β and PKC-β in endothelial cells. Arterioscler Thromb Vasc Biol. 2008;28(5):919-924.
48. de Heuvel E, Wallace L, Sharkey KA, Sigalet DL. Glucagon-like peptide 2 induces vasoactive intestinal polypeptide expression in enteric neurons via phophatidylinositol 3-kinase-β signaling. Am J Physiol Endocrinol Metab. 2012;303(8):E994-E1005.
49. Mattson DL, Bellehumeur TG. Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension. 1996; 28(2):297-303.
50. BohlenHG.Rapid and slow nitric oxide responses during conducted vasodilation in the in vivo intestine and brain cortex microvasculatures. Microcirculation. 2011;18(8):623-634.
51. Canani RB, Cirillo P, Buccigrossi V, et al. Nitric oxide produced by the enterocyte is involved in the cellular regulation of ion transport. Pediatr Res. 2003;54(1):64-68.
52. Jia J, Arif A, Terenzi F, et al. Target-selective protein s-nitrosylation by sequence motif recognition. Cell. 2014;159(3):623-634.
53. Berg JK, Kim EH, Li B, Joelsson B, Youssef NN. A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects. BMC Gastroenterol. 2014;14:25.
54. Fischer KD, Dhanvantari S, Drucker DJ, Brubaker PL. Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats. Am J Physiol. 1997;267(4):E815.
55. Verdam FJ, Greve JW, Roosta S, et al. Small intestinal alterations in severely obese hyperglycemic subjects. J Clin Endocrinol Metab. 2011;96(2):E379-E383.
56. Takata Y, Kawamura R, Onuma H, Osawa H. Different than glucagon-like peptide (GLP)-1, GLP-2 is associated with obesity and postprandial lipemia in subjects with diabetes. Diabetes. 2015; 64(suppl 1):698-P (Abstract).